FR6684M - Nouveau médicament notamment pour le traitement de l’hyperandrogénie. - Google Patents

Nouveau médicament notamment pour le traitement de l’hyperandrogénie.

Info

Publication number
FR6684M
FR6684M FR131869A FR131869A FR6684M FR 6684 M FR6684 M FR 6684M FR 131869 A FR131869 A FR 131869A FR 131869 A FR131869 A FR 131869A FR 6684 M FR6684 M FR 6684M
Authority
FR
France
Prior art keywords
hyperandrogenism
treatment
new drug
drug especially
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR131869A
Other languages
English (en)
Inventor
Nedelec Lucien
Gasc Jean-Claude
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR131869A priority Critical patent/FR6684M/fr
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to CH1848168A priority patent/CH500181A/fr
Priority to CH499270A priority patent/CH505804A/fr
Priority to NL6817702A priority patent/NL6817702A/xx
Priority to IL31254A priority patent/IL31254A/xx
Priority to DK606768AA priority patent/DK121554B/da
Priority to DE19681814304 priority patent/DE1814304C3/de
Priority to GB59263/68A priority patent/GB1202757A/en
Priority to FR179556A priority patent/FR309F/fr
Application granted granted Critical
Publication of FR6684M publication Critical patent/FR6684M/fr
Priority to US00186483A priority patent/US3810885A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03BAPPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B27/00Photographic printing apparatus
    • G03B27/32Projection printing apparatus, e.g. enlarger, copying camera
    • G03B27/52Details
    • G03B27/62Holders for the original

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR131869A 1967-12-12 1967-12-12 Nouveau médicament notamment pour le traitement de l’hyperandrogénie. Expired FR6684M (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR131869A FR6684M (fr) 1967-12-12 1967-12-12 Nouveau médicament notamment pour le traitement de l’hyperandrogénie.
CH499270A CH505804A (fr) 1967-12-12 1968-12-10 Procédé de préparation de nouveaux 3-oxo 12-méthyl estratriènes
NL6817702A NL6817702A (fr) 1967-12-12 1968-12-10
IL31254A IL31254A (en) 1967-12-12 1968-12-10 12-methyl-3-keto-estratrienes and process for preparing same
CH1848168A CH500181A (fr) 1967-12-12 1968-12-10 Procédé de préparation de nouveaux 3-oxo 12-méthyl estratriènes
DK606768AA DK121554B (da) 1967-12-12 1968-12-12 Analogifremgangsmåde til fremstilling af 3-oxo-12-methylestra-4,9,11-triener.
DE19681814304 DE1814304C3 (de) 1967-12-12 1968-12-12 3-Oxo-12-methyl-östra-4,9*ll-triene, Verfahren zu ihrer Herstellung, diese enthaltende therapeutische Zusammensetzungen sowie die entsprechenden Zwischenprodukte
GB59263/68A GB1202757A (en) 1967-12-12 1968-12-12 Novel estra-4,9,11-trien-3-ones, processes for their preparation, compositions incorporating them, and intermediates therefor
FR179556A FR309F (fr) 1967-12-12 1968-12-20 Nouveau médicament notamment pour le traitement de l’hyperandrogénie.
US00186483A US3810885A (en) 1967-12-12 1971-10-04 Novel steroids and processes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR131869A FR6684M (fr) 1967-12-12 1967-12-12 Nouveau médicament notamment pour le traitement de l’hyperandrogénie.

Publications (1)

Publication Number Publication Date
FR6684M true FR6684M (fr) 1969-03-17

Family

ID=8643086

Family Applications (2)

Application Number Title Priority Date Filing Date
FR131869A Expired FR6684M (fr) 1967-12-12 1967-12-12 Nouveau médicament notamment pour le traitement de l’hyperandrogénie.
FR179556A Expired FR309F (fr) 1967-12-12 1968-12-20 Nouveau médicament notamment pour le traitement de l’hyperandrogénie.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR179556A Expired FR309F (fr) 1967-12-12 1968-12-20 Nouveau médicament notamment pour le traitement de l’hyperandrogénie.

Country Status (6)

Country Link
CH (2) CH500181A (fr)
DK (1) DK121554B (fr)
FR (2) FR6684M (fr)
GB (1) GB1202757A (fr)
IL (1) IL31254A (fr)
NL (1) NL6817702A (fr)

Also Published As

Publication number Publication date
IL31254A0 (en) 1969-02-27
CH500181A (fr) 1970-12-15
DE1814304A1 (de) 1969-06-19
NL6817702A (fr) 1969-06-16
FR309F (fr) 1970-04-20
IL31254A (en) 1973-05-31
DK121554B (da) 1971-11-01
GB1202757A (en) 1970-08-19
DE1814304B2 (de) 1977-06-08
CH505804A (fr) 1971-04-15

Similar Documents

Publication Publication Date Title
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
FI50707C (fi) Menetelmä uusien farmakologisesti vaikuttavien hydroksisykloheksyyliam iinien valmistamiseksi.
BE754628A (fr) Retracteur pour le traitement des hemorroides
FR3056M (fr) Nouveau médicament pour les malaises hépatiques.
FI51175C (fi) Menetelmä terapeuttisesti käytettävien indanyylitiokarbamaattien valmi stamiseksi.
FR6684M (fr) Nouveau médicament notamment pour le traitement de l’hyperandrogénie.
FR1401447A (fr) Chevalet pour ampoules pharmaceutiques
FR1538441A (fr) Baignoire pour le traitement de malades
FR3066M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
FR2193M (fr) Nouveau médicament pour le traitement des maladies infectieuses.
FR3670M (fr) Nouveau médicament applicable par voie orale pour le traitement d'ulcérations chroniques des tissus.
FR3875M (fr) Nouveau médicament convenant notamment au traitement des infections tuberculeuses.
FR3500M (fr) Nouveau médicament destiné au traitement des rhinites.
FR2346M (fr) Médicament pour le traitement des colopathies.
FR363M (fr) Nouveau médicament pour le traitement des trypanosomoses, des salmonelloses et des infections pénicillo-résistantes.
FR2024194A1 (fr) Medicament pour le traitement de la coccidiose
FR1494017A (fr) Support pour traitement radiologique
FR3096M (fr) Nouveau médicament notamment pour le traitement des états d'adynamie.
OA01758A (fr) Procédé pour la préparation de compositions pharmaceutiques.
FR5756M (fr) Médicament pour le traitement du syndrome prémenstruel
FR1475763A (fr) Boîte pour ampoules pharmaceutiques
FR3641M (fr) Nouveau médicament notamment pour le traitement des états d'adynamie.
FR2839M (fr) Médicament nouveau pour la thérapeutique des oedemes localisés et des cicatrisations des muqueuses.
FR3633M (fr) Nouveau médicament pour traiter l'alcoolémie.
FR2853M (fr) Nouveau médicament, notamment pour le traitement des infections dues a des staphylocoques.

Legal Events

Date Code Title Description
ST Notification of lapse